1338 related articles for article (PubMed ID: 26311867)
1. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
2. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
Schnell G; Loo YM; Marcotrigiano J; Gale M
PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
Saito T; Owen DM; Jiang F; Marcotrigiano J; Gale M
Nature; 2008 Jul; 454(7203):523-7. PubMed ID: 18548002
[TBL] [Abstract][Full Text] [Related]
4. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
[TBL] [Abstract][Full Text] [Related]
5. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
6. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
8. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
Sooryanarain H; Heffron CL; Meng XJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
[TBL] [Abstract][Full Text] [Related]
9. [RIG-I mediated hepatic innate immune signaling that controls HCV infection].
Saito T; Gale M
Uirusu; 2008 Dec; 58(2):105-15. PubMed ID: 19374189
[TBL] [Abstract][Full Text] [Related]
10. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
Uzri D; Gehrke L
J Virol; 2009 May; 83(9):4174-84. PubMed ID: 19224987
[TBL] [Abstract][Full Text] [Related]
12. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
13. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
[TBL] [Abstract][Full Text] [Related]
14. RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.
Ireton RC; Wilkins C; Gale M
Methods Mol Biol; 2017; 1656():119-129. PubMed ID: 28808965
[TBL] [Abstract][Full Text] [Related]
15. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
18. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
[TBL] [Abstract][Full Text] [Related]
19. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
Oshiumi H; Miyashita M; Matsumoto M; Seya T
PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
